AWM
GILD icon

AE Wealth Management’s Gilead Sciences GILD Stock Holding History

AE Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,000
Closed -$3K – 1513
2020
Q4 		$3K Buy
+2,000
New +$121K ﹤0.01% 1352

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AE Wealth Management's GILD Position: Q2 2026 in Review

AE Wealth Management increased its Gilead Sciences (GILD) stake by 22% in Q2 2026, buying an estimated $1.89M and bringing the position to 79,370 shares worth $10M. The position accounts for 0.05% of the portfolio, ranked #306.

AE Wealth Management first reported a position in GILD in Q3 2017 and has held it in 36 quarters since. The position peaked at $29.7M in Q1 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • AE Wealth Management held 79,370 shares of Gilead Sciences worth $10M as of Q2 2026.
  • AE Wealth Management bought 14,317 Gilead Sciences shares in Q2 2026, an estimated $1.89M.
  • Gilead Sciences made up 0.05% of AE Wealth Management's portfolio in Q2 2026, its #306 holding.
  • AE Wealth Management first reported a position in Gilead Sciences in Q3 2017 and has held it in 36 quarters since.
  • AE Wealth Management's Gilead Sciences position peaked at $29.7M in Q1 2023.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.